CD19 and type 2 diabetes mellitus: In the presence of T2DM, 131I led to an increase in the serum TNFR2 concentration (P = 0.01), CD19 + B-lymphocytes (P = 0.03), and a reduction in CD8 + T-cells count number (P = 0.02).